Cytogenetic study of the induction mechanism of chromosome-type aberrations by 1-β-d-arabinofuranosylcytosine

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 619, Issue 1-2, 2007, Pages 1-8

  Sekizawa, Koichi ^a   Suzuki, Toshimitsu ^a,b   Kishi, Kunikazu ^a  

^a KYORIN UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

1 d Arabinofuranosylcytosine; Chromosome type aberration; DNA double strand break; DNA repair; Endonucleolytic protein(s)

Indexed keywords

CYCLOHEXIMIDE; CYTARABINE; DOUBLE STRANDED DNA; PROTEIN SYNTHESIS INHIBITOR;

ARTICLE; CELL CYCLE G1 PHASE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DENDRITIC CELL; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RING CHROMOSOME;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CHROMOSOME ABERRATIONS; CYCLOHEXIMIDE; CYTARABINE; CYTOGENETICS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; MUTAGENS; PLASMIDS; PROTEIN SYNTHESIS INHIBITORS; SISTER CHROMATID EXCHANGE;

EID: 34247099757     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.09.011     Document Type: Article

References (38)

1. 1 phase of clastgen-treated human lymphocytes on the frequencies of chromosome-type and chromatid-type aberrations and sister-chromatid exchanges. Mutat. Res. 176 (1987) 105-116
2. Kishi K., Homma A., Kawa A., and Kadowaki K. Age related change in the frequency of AraC-induced chromosome aberrations in human peripheral blood lymphocytes. Mech. Ageing Dev. 37 (1987) 211-219
3. Brewen J.G., and Christie N.T. Studies on the induction of chromosomal aberrations in human leukocytes by cytosine arabinoside. Exp. Cell Res. 46 (1967) 276-291
4. Preston R.J. The effect of cytosine arabinoside on the frequency of X-ray-induced chromosome aberrations in normal human leukocytes. Mutat. Res. 69 (1980) 71-79
5. Hiss E.A., and Preston R.J. The effect of cytosine arabinoside on the frequency of single-strand breaks in DNA of mammalian cells following irradiation or chemical treatment. Biochim. Biophys. Acta 478 (1977) 1-8
6. Yoshida S., Yamada M., and Masaki S. Inhibition of DNA polymerase-alpha and -beta of calf thymus by 1-β-d-arabinofuranosylcytosine-5′-triphosphate. Biochim. Biophys. Acta 477 (1977) 144-150
7. Fram R.J., and Kufe D.W. DNA strand breaks caused by inhibitors of DNA synthesis: 1-β-d-arabinofuranosylcytosine and aphidicolin. Cancer Res. 42 (1982) 4050-4053
8. Matsukage A., Ono K., Ohashi A., Takahashi T., Nakayama C., and Saneyoshi M. Inhibitory effect of 1-β-d-arabinofuranosylcytosine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Cancer Res. 38 (1978) 3076-3079
9. Dicioccio R.A., and Srivastava B.I. Kinetics of inhibition of deoxynucleotide-polymerizing enzyme activities from nomal and leukemic human cells by 9-β-d-arabinofuranosylcytosine 5'-triphoshate and 1-β-d-arabinofuranosylcytosine 5'-triphoshate. Eur. J. Biochem. 79 (1977) 411-418
10. Bassi L., Carloni M., Meschini R., Fonti E., and Palitti F. X-irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin-dependent apoptosis. Int. J. Radiat. Biol. 79 (2003) 943-954
11. Mosesso P., Schuber M., Seibt D., Schmitz C., Fiore M., Schinoppi A., Penna S., and Palitti F. X-ray-induced chromosome aberrations in human lymphocytes in vitro are potentiated under simulated microgravity conditions (Clinostat). Phys. Med. 17 (2001) 264-266
12. Okayasu R., and Iliakis G. Evidence that the product of the xrs gene is predominantly involved in the repair of a subset of radiation-induced interphase chromosome breaks rejoining with fast kinetics. Radiat. Res. 138 (1994) 34-43
13. Sanford K.K., Parshad R., Price F.M., Tarone R.E., and Schapiro M.B. X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness. Cancer Genet. Cytogenet. 70 (1993) 25-30
14. Bryant P.E., and Johnston P.J. Restriction-endonuclease-induced DNA double-strand breaks and chromosomal aberrations in mammalian cells. Mutat. Res. 299 (1993) 289-296
15. Angeli J.P., Ribeiro L.R., Bellini M.F., and Mantovanil. Anti-clastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells. Hum. Exp. Toxicol. 25 (2006) 319-324
16. Shao R.G., Cao C.X., and Pommier Y. Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells. Acta Pharmacol. Sin. 25 (2004) 756-762
17. van Waardenburg R.C., de Jong L.A., van Delft F., van Eijndhoven M.A., Bohlander M., Bjornsti M.A., Brouwer J., and Schellens J.H. Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons. Mol. Cancer Ther. 3 (2004) 393-402
18. Severin I., Padieu M., Lhuguenot J.C., and Chagnon M.C. Toxic interaction between hydroxyurea and 1-beta-d-arabino-furanosylcytosine on the DNA of a human hepatoma cell line (HEPG2). Toxicol. Lett. 145 (2003) 303-311
19. Bierau J., Van Gennip A.H., Leen R., Helleman J., Caron H.N., and Van Kuilenburg A.B. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity. Int. J. Cancer 103 (2003) 387-392
20. Laack N.N., Ballman K.V., Brown P.B., and O'neill B.P. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma. Int. J. Radiat. Oncol. Biol. Phys. 65 (2006) 1429-1439
21. Jin J., Jiang D.Z., Mai W.Y., Meng H.T., Qian W.B., Tong H.Y., Huang J., Mao L.P., Tong Y., Wang L., Chen Z.M., and Xu W.L. Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia. Leukemia 20 (2006) 1361-1367
22. Buchner T., Berdel W.E., Schoch C., Haferlach T., Serve H.L., Kienast J., Schnittger S., Kern W., Tchinda J., Reichle A., Lengfelder E., Staib P., Ludwig W.D., Aul C., Eimermacher H., Balleisen L., Sauerland M.C., Heinecke A., Wormann B., and Hiddemann W. Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia. J. Clin. Oncol. 24 (2006) 2480-2489
23. Abe S., Funato T., Takahashi S., Yokoyama H., Yamamoto J., Tomiya Y., Yamada-Fujiwara M., Ishizawa K., Kameoka J., Kaku M., Harigae H., and Sasaki T. Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia. Tohoku J. Exp. Med. 209 (2006) 217-228
24. Nakamura T., Takauji R., Kamiya K., Kawai Y., Iwasaki H., Tohyama K., Yamauchi T., and Ueda T. Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy. Leukemia 11 (1997) 548-551
25. de Vries J.F., Falkenburg J.H., Willemze R., and Barge R.M. The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells. Haematologica 91 (2006) 912-919
26. Moore I.M., Merkle C.J., Miketova P., Salyer R.K., Torres B.J., Chaeffer Jr. S.R.C., and Montgomery D.W. Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway. Biol. Res. Nurs. 7 (2006) 289-296
27. Matsuda A., and Sasaki T. Antitumor activity of sugar-modified cytosine nucleosides. Cancer Sci. 95 (2004) 105-111
28. Wang S., Vrana J.A., Bartimole T.M., Freemerman A.J., Jarvis W.D., Kramer L.B., rystal K.G., Dent P., and Grant S. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-d-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Mol. Pharmacol. 52 (1997) 1000-1009
29. Hunakova L., Sulikova M., Duraj J., Sedlak J., and Chorvath B. Stimulation of 1-(beta-d-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors. Neoplasma 43 (1996) 291-295
30. Bender M.A., and Preston R.J. Role of base damage in aberration formation: interaction of aphidicolin and X-rays. Prog. Mutat. Res. 4 (1982) 37-46
31. Dedon P.C., and Goldberg I.H. Influence of thiol structure on neocarzinostatin activation and expression of DNA damage. Biochemistry 31 (1992) 1909-1917
32. McAfee S.E., and Ashley G.W. Modulation of neocarzinostatin-mediated DNA double strand damage by activating thiol: deuterium isotope effects. Nucleic Acids Res. 20 (1992) 805-809
33. Dedon P.C., Jiang Z.W., and Goldberg I.H. Neocarzinostatin-mediated DNA damage in a model AGT.ACT site: mechanistic studies of thiol-sensitive partitioning of C4′ DNA damage products. Biochemistry 31 (1992) 1917-1927
34. Kuo W.L., Meyn R.E., and Haidle C.W. Neocarzinostatin-mediated DNA damage and repair in wild-type and repair-deficient Chinese hamster ovary cells. Cancer Res. 44 (1984) 1748-1751
35. Tollefsbol T.O., and Cohen H.J. The protein synthetic surge in response to mitogen triggers high glycolytic enzyme levels in human lymphocytes and occurs prior to DNA synthesis. Biochem. Med. Metab. Biol. 44 (1990) 282-291
36. Costa N.D., and Bryant P.E. Elevated levels of DNA double -strand breaks (dsb) in restriction endonuclease-treated xrs5 cells correlate with the reduced capacity to repair dsb. Mutat. Res. 255 (1991) 219-226
37. Pantelias G.E., and Wolff S. Cytosine arabinoside is a potent clastogen and does not affect the repair of X-ray-induced chromosome fragments in unstimulated human lymphocytes. Mutat. Res. 151 (1985) 65-72
38. Sasaki M.S. Radiation damage and its repair in the formation of chromosome aberrations in human lymphocytes. In: Evans H.J., and Lloyd D.C. (Eds). Mutagen-induced Chromosome Damage in Man (1978), Edinburgh University Press, Edinburgh 62-76